文献速递免疫规划

为皮内和经皮ETEC疫苗临床试验开发的局部皮肤反应分级系统

A grading system for local skin reactions developed for clinical trials of an intradermal and transcutaneous ETEC vaccine.
PubMed 文献 · Vaccine · 2020-04-03

研究组为皮内和经皮接种产肠毒素大肠杆菌(ETEC)疫苗的早期临床试验开发了疫苗部位外观分级量表(VSAGS),用于评估和比较皮肤反应。综述现有文献发现,经皮免疫常见红斑丘疹和瘙痒,皮内接种常见红斑、硬结和色素改变,但此前无标准化方法描述皮肤表现谱。该分级量表有助于记录和比较皮肤不良事件。

要点

  • 经皮免疫最常见的局部不良事件为红斑丘疹和瘙痒。
  • 皮内接种常见红斑、硬结及色素改变。
  • VSAGS聚焦皮肤改变的病理生理表现,便于比较不同途径和产品的局部反应。

核心结论

  • 皮内和经皮接种与大体可预测的皮肤不良事件谱相关,聚焦皮肤外观改变的分级量表有助于比较皮肤不良事件,标准化分级量表将促进皮肤不良事件的记录和比较。

研究设计与样本

  • 研究组在皮内和经皮ETEC疫苗候选(黏附素疫苗联合LTR192G)早期临床试验前,回顾现有局部疫苗部位反应表征方法并制定标准化疫苗部位外观分级量表(VSAGS)。

主要发现

  • 已发表报告数据显示,经皮免疫相关最常见的局部不良事件为红斑丘疹和瘙痒。
  • 不同研究间反应频率差异显著,经皮免疫接种方法和产品亦各异。
  • 皮内接种通常导致疫苗部位红斑和硬结以及色素改变。
  • 此前无已发表方法可表征皮肤表现谱。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trials assessing the safety of novel vaccine candidates are essential in the evaluation and development of candidate vaccines. Immunogenicity and dose-sparing features of vaccination approaches which target skin and associated tissues have garnered increased interest; for enteric vaccines, cutaneous vaccination has been of particular interest. Cutaneous vaccine site reactions are among the most common and visible vaccine related adverse events (AEs) when skin routes are used. Regulatory guidelines governing classification of severity focus on functional impact but are insufficient to characterize a spectrum of skin reaction and allow for comparisons of routes, doses and products with similar local cutaneous AEs. OBJECTIVES: Our group developed a grading scale to evaluate and compare cutaneous vaccine site reactions ahead of early-phase clinical trials of intradermal (ID) and transcutaneous immunization (TCI) with enterotoxigenic E.coli (ETEC) vaccine candidates (adhesin-based vaccine co-administered with LTR192G). We reviewed existing methods for characterizing the appearance and severity of local vaccine site reactions following TCI and ID vaccination and devised a standardized vaccine site appearance grading scale (VSAGS) for use in the clinical development of novel ETEC vaccine candidates which focused on pathophysiologic manifestation of skin findings. RESULTS: Available data from published reports revealed erythematous papules and pruritus were the most common local AEs associated with TCI. Frequency of reactions varied notably across studies as did TCI vaccination methodologies and products. ID vaccination commonly results in erythema and induration at the vaccine site as well as pigmentation changes. There was no published methodology to characterize the spectrum of dermatologic findings. CONCLUSION: ID and TCI vaccination are associated with a largely predictable range of cutaneous AEs. A grading scale focused on the appearance of cutaneous changes was useful in comparing cutaneous AEs. A standardized grading scale will facilitate documentation and comparison of cutaneous AEs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gutiérrez RL, Porter CK, Jarell A, et al. A grading system for local skin reactions developed for clinical trials of an intradermal and transcutaneous ETEC vaccine. Vaccine. 2020. PMID: 32253098. doi:10.1016/j.vaccine.2020.02.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。